Company Overview of Eagle Vision Pharmaceutical Corporation
Eagle Vision Pharmaceutical Corporation engages in the development of injectable imaging agents. The company develops a non-radioactive imaging agent that enhance the power of magnetic resonance imaging (MRI) to revolutionize the diagnosis and management of heart disease, liver disease, and cancer. Its product is primarily used to harness the power of MRI in the areas of cardiac perfusion, cardiac function, and cardiac vessel status. Eagle Vision Pharmaceutical Corporation was founded in 1998 and is based in Downingtown, Pennsylvania.
175 Krauser Road
Downingtown, PA 19335
Founded in 1998
Key Executives for Eagle Vision Pharmaceutical Corporation
Similar Private Companies By Industry
|21st Century Animal Health||United States|
|3 Buds' Organics LLC||United States|
|4P Therapeutics LLC||United States|
|60° Pharmaceuticals, LLC||United States|
|7 Oaks Pharmaceutical Corp.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.
Most Searched Private Companies
|Company Name||Geographic Region|
|Lawyers Committee for Civil Rights Under Law||United States|
|NYC2012, Inc.||United States|
|Rush University||United States|
|The Advertising Council, Inc.||United States|
Sponsored Financial Commentaries
Only a company representative may request an update for the company profile. Documentation will be required.
To contact Eagle Vision Pharmaceutical Corporation, please visit --. Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.